Avantor, Inc. (NYSE:AVTR) Receives $27.40 Consensus PT from Analysts

Avantor, Inc. (NYSE:AVTR) has received an average rating of “Moderate Buy” from the sixteen brokerages that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $27.40.

Several analysts have issued reports on the company. Citigroup cut Avantor from a “buy” rating to a “neutral” rating and dropped their target price for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Morgan Stanley upped their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Robert W. Baird lifted their target price on shares of Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. TD Cowen increased their price target on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Finally, Wells Fargo & Company started coverage on shares of Avantor in a research report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 price target on the stock.

Insider Buying and Selling

In other news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.50% of the stock is owned by corporate insiders.

Institutional Trading of Avantor

Hedge funds have recently modified their holdings of the stock. Boston Partners lifted its stake in Avantor by 2.2% in the first quarter. Boston Partners now owns 28,561,802 shares of the company’s stock worth $729,298,000 after acquiring an additional 624,369 shares during the last quarter. Canada Pension Plan Investment Board increased its position in Avantor by 6.8% during the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after buying an additional 1,463,695 shares during the period. Artemis Investment Management LLP lifted its stake in Avantor by 14.9% in the first quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock valued at $233,109,000 after buying an additional 1,180,937 shares during the last quarter. 1832 Asset Management L.P. boosted its holdings in shares of Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the period. Finally, Bessemer Group Inc. increased its holdings in shares of Avantor by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 7,099,848 shares of the company’s stock valued at $181,544,000 after acquiring an additional 297,534 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Performance

AVTR opened at $27.70 on Tuesday. Avantor has a twelve month low of $16.63 and a twelve month high of $28.00. The firm has a market capitalization of $18.82 billion, a PE ratio of 71.03, a PEG ratio of 2.75 and a beta of 1.32. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The firm’s 50-day moving average price is $24.92 and its 200 day moving average price is $24.35.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. As a group, sell-side analysts expect that Avantor will post 1.01 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.